Showing results (361-370 of 2,280) with videos related to
Sort By:
Pageof 228
HIV Medicine|November 17, 2020
Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIVW M Han, A Jiamsakul, J Jantarapakde, et al.HIV Medicine|November 20, 2020
Healthcare delivery for HIV-positive people with tuberculosis in EuropeA K Bentzon, A Panteleev, V Mitsura, et al.HIV Medicine|September 2, 2020
Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohortNicolò Girometti, Frances Lander, Alan McOwan, et al.HIV Medicine|September 3, 2020
Universal test and treat in relation to HIV disease progression: results from a stepped-wedge trial in EswatiniC E Boeke, S Khan, F Walsh, et al.HIV Medicine|September 3, 2020
Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in BotswanaT B Leeme, M Mine, K Lechiile, et al.HIV Medicine|September 3, 2020
Short- and medium-term prognosis of HIV-infected patients receiving intensive care: a Brazilian multicentre prospective cohort studyH B Andrade, Irf da Silva, G V Ramos, et al.HIV Medicine|September 5, 2020
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0L Ryom, A Cotter, R De Miguel, et al.HIV Medicine|November 24, 2020
Pneumocystis jirovecii pneumonia PCR test on upper respiratory tract swabV Sivaraj, P Cliff, S Douthwaite, et al.HIV Medicine|February 5, 2020
The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single-tablet regimen in the expanding spectrum of fixed-dose combination therapy for HIVH-J Stellbrink, A Lazzarin, I Woolley, et al.HIV Medicine|July 29, 2015
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D studyA C Achhra, A Mocroft, P Reiss, et al.Pageof 228